Parents, check your pantries; one of the biggest baby food companies is recalling a snack over potential contamination. On Monday, January 26, Gerber Products Company confirmed it is voluntarily recalling multiple batches of its arrowroot biscuits after discovering the possible presence of foreign material. The company said the decision was made “out of an abundance of caution” following a supplier-related issue.   According to Gerber, 21 batches of the 5.5-ounce snack sold across the U.S. and select international markets may contain “soft plastic and/or paper pieces that should not be consumed.” The issue was traced back to an arrowroot flour supplier that has since initiated its own recall. "Consumers who may have purchased impacted Gerber Arrowroot Biscuits should not feed this product to their child,” the company warned in its memo. Gerber stated that no illnesses or injuries had been reported as of January 26. The company also confirmed it is “no longer working with the flour supplier” connected to the issue. Parents and caregivers who purchased the affected products are advised to return them to the original place of purchase for a full refund. Gerber emphasized that no other products in its lineup are impacted. The recalled biscuits are sold in a light blue container labeled for babies at the “crawler” stage, meaning children over 10 months old. Production dates range from July 2025 through September 2025, with best-before dates between October 16, 2026, and December 16, 2026. Gerber said it is “working closely with the U.S. Food & Drug Administration and will cooperate fully throughout their review.” “The quality, safety, and integrity of our products remain our highest priority, and we take this responsibility seriously,” the company said. “We sincerely apologize for any concerns or inconvenience this action causes for parents, caregiver,s and retail customers.” The recall has also been shared by retailers and international agencies, including the Government of Canada and the Singapore Food Agency.

The effect of microdosing have been overstated, at least when it comes to depression.